PRIMARY STUDY
The Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory.
Key Findings: The authors of this review suggest that CB1 may undergo modifications in renal tumors at the post-transcriptional level thus suggesting an increasing complexity and need for further studies to better understand the role of the ECS in renal cancers.
Type of Study: Meta-analysis
Study Result: Positive
Research Location(s): Poland
Year of Pub: 2016
Cannabinoids Studied:
Phytocannabinoid Source: Not Applicable
Receptors Studied: CB1, CB2
Citation: Khan MI, et al. The Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory. Curr Pharm Des. 2016; 22:1756-66. doi: 10.2174/1381612822666151211094901
Authors: Khan MI, Sobocińska AA, Czarnecka AM, Król M, Botta B, Szczylik C
